4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000138
Director sold 1,666 shares at an average $23.62 ($39,348)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-09-15 | Sale 10b5-1 | −1,626 | $23.60 | $38,374 | 129,745 | D: show line 1 in the form |
| SATO VICKI L Director | 2023-09-15 | Sale 10b5-1 | −40 | $24.35 | $974 | 129,705 | D: show line 2 in the form |
| Open-market sales · 1,666 sh · avg $23.62 · $39,348 | |||||||
Loading xslF345X05/wk-form4_1695156311.xml…